Tagged with R

Indian Drug Manufacturers' Association (IDMA) Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue in the coming years. Today this is a crucial moment for India: the industry is at a crossroad. How has…

Ferring Pharmaceuticals Poland As we are just entering 2011, could you share with us the results of the Polish affiliate in 2010? 2010 was for Ferring Poland a year of reconstruction. The affiliate has been rebuilding the business with significant internal changes that are supposed to reflect changes in the external environment. The…

Pharmaceutical Services Division Malaysia The Pharmaceutical Services Division has been around since 1951, what have been the major shifts in its objectives since then? When the pharmacy service came into existence in this country it operated under British law and the acts and therefore regulations have been in place since before Malaysia’s independence. Malaysia…

Deloitte Netherlands Deloitte is renowned for its strong network of international expertise. Yet every market has its own particularities… Having spent 16 years with the company, in your opinion, what is it that your clients struggle with the most in the Netherlands? What you see here in the Dutch market, is a…

Leiden University Medical Center (LUMC) Your role as Chair of the Executive Board is a mix between CEO and CMO. On a daily basis, which do you see yourself as more – the Chief Executive Officer of the hospital or the Chief Medical Officer? The choice to have a Chairman of the Executive Board with…

Organisation of Pharmaceutical Producers of India (OPPI) Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen happening in the industry since then? There has been a paradigm shift with the Product Patent Regime coming in place in 2005. The era from 1970 to 2005 has…

Pyridam Farma Pyridam Farma has achieved and maintained the leading position in terms of growth in the Indonesian pharmaceutical industry for two years. What strategic choices have caused Pyridam to outperform its peers? Our strategy has three pillars: marketing, human resources, and quality. Three years ago Pyridam Farma redesigned its marketing strategies,…

Cambridge Major Laboratories Europe It has now been 12 years since you co-founded ChemShop. One of the busiest, but probably most exciting moments in that period must have been the merger with CML in 2007. At that time, now global CEO Michael Major spoke of seamless integration. Was it really that easy in practice?…

Quintiles Netherlands As an expatriate executive, you seem to be fully integrated into the local community. Can you explain to our readers what brought you here to the Netherlands? The quick answer is the charm of the Dutch. Perhaps more importantly, what’s kept me here has been the opportunity to be involved…

Beurs van Berlage The Beurs van Berlage, conference centre in the heart of Amsterdam, dates back to the year 1903, and is a significant Dutch monument and unique event center that has become a famous heritage of the country. In what ways does Beurs van Berlage reflect and serve the city of Amsterdam…

Atlantic Healthcare Ltd A key milestone for Atlantic Healthcare was the deal with Isis Pharmaceuticals for alicaforsen in 2007. In 2008, alicaforsen acquired orphan drug status in the U.S.; in 2009, orphan status was granted in Europe. Many companies in the UK have named market access as a key challenge—but is that an…

Merck Sp. z.o.o You joined Merck in September 1996, took gradually increasing positions at Merck, from Medical Representative (1996 – 1998), to Sales and Marketing managing positions and you were ultimately appointed Managing Director Poland in January 2008. What have been the major challenges you faced in almost three years now? Merck in…